Literature DB >> 18300034

Morphologic heterogeneity of renal light-chain deposition disease.

Neriman Gokden1, Bart Barlogie, Helen Liapis.   

Abstract

Light-chain deposition disease (LCDD) of the kidney is defined as deposition of monotypic light chains (LC) within glomerular (GBM) and tubular (TBM) basement membranes. The morphologic features of pure renal LCDD have been presented only in case reports or small series. The aim of this study was to perform a comprehensive evaluation of the light (LM), immunofluorescence (IF), and electron microscopic (EM) features of pure renal LCDD in a large series of biopsies. Out of 46 cases assembled, 42 had multiple myeloma, 2 had monoclonal gammopathy of unknown significance, and in 2 patients no lymphoproliferative disease was identified. The most common LM lesion of LCDD, nodular glomerulosclerosis, was present in only 14 (30%) cases. GBM and/or TBM thickening was found in 3 (6%), mild to moderate mesangial matrix increase in 12 (23%), and unremarkable glomeruli and tubules were seen in 15 (32%) cases. Forty-two had IF and 40 (92%) showed characteristic linear LC immunoreactivity (24 kappa, 16 lambda) along GBM and/or TBM. Among 39 cases in which IF and EM was available, 25 (64%) were positive by both. Two (6%) were negative by IF, but had deposits by EM. In 12 (30%) with immunoreactivity to LC (4 kappa, 8 lambda), no deposits were identified ultrastructurally. This study shows heterogeneous LM lesions in pure LCDD cases. LM alone may be suspicious but not diagnostic of LCDD. Immunofluorescence is more sensitive than EM for detection of LC for the definitive diagnosis of LCDD. This study supports the importance of utilizing kappa and lambda stains in the routine IF panel for diagnosis of LCDD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300034     DOI: 10.1080/01913120701854002

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  7 in total

1.  Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.

Authors:  Helen Gharwan; Cristina I Truica
Journal:  Med Oncol       Date:  2011-04-09       Impact factor: 3.064

2.  Hypertension, renal failure, and edema in a 38-year-old man: light chain deposition disease; a case report and review of the literature.

Authors:  Sarmad Said; Chad J Cooper; Azikiwe C Nwosu; Jorge E Bilbao; German T Hernandez
Journal:  J Nephropathol       Date:  2014-04-01

3.  Five Sequential Evaluations of Renal Histology in a Patient with Light Chain Deposition Disease.

Authors:  Toshiharu Ueno; Koichi Kikuchi; Ryo Hazue; Koki Mise; Keiichi Sumida; Noriko Hayami; Tatsuya Suwabe; Junichi Hoshino; Naoki Sawa; Kenji Arizono; Shigeko Hara; Kenmei Takaichi; Takeshi Fujii; Kenichi Ohashi; Yoshifumi Ubara
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

4.  Treatment of Light Chain Deposition Disease Using Bortezomib-Based Regimen Followed by Thalidomide-Based Regimen in a Saudi Male.

Authors:  Bappa Adamu; Mushabab Al-Ghamdi; Mustafa Ahmad; Khaled O Alsaad
Journal:  Case Rep Nephrol       Date:  2016-12-19

Review 5.  The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.

Authors:  Şadiye Mehtat Ünlü; Hayri Özsan; Sülen Sarıoğlu
Journal:  Turk J Haematol       Date:  2017-08-23       Impact factor: 1.831

6.  Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions.

Authors:  Tomomichi Kasagi; Hironobu Nobata; Keisuke Suzuki; Naoto Miura; Shogo Banno; Akiyoshi Takami; Taro Yamashita; Yukio Ando; Hirokazu Imai
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

7.  An unusual cause of gross hematuria and renal dysfunction in a young male.

Authors:  M Rathi; R Ramachandran; H S Kohli; R Nada; V Jha; V Sakhuja
Journal:  Indian J Nephrol       Date:  2013-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.